Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Human artificial chromosome vector

a technology of artificial chromosomes and vectors, applied in the field of human artificial chromosome vectors, can solve the problems of limited development of the use of them, and achieve the effects of high efficiency, stably produced, and high efficiency

Inactive Publication Date: 2012-09-13
SANFORD APPLIED BIOSCI
View PDF4 Cites 32 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

"The present invention relates to a human artificial chromosome vector that includes a human antibody heavy chain gene, a human antibody light chain gene, and a surrogate light chain gene. The vector can be introduced into a non-human animal to produce a chimeric animal that maintains the vector. The vector can also be used to produce human polyclonal antibodies in a transgenic animal. The invention provides a way to produce human polyclonal antibodies with a desired antigen reactivity or titer, and a way to eliminate bovine antibodies produced in a bovine living body."

Problems solved by technology

In addition, due to factors such as the kind of antigen, the number of exposure to an immunogen, and the amount of donor serum which may be collected, in preparing a polyclonal antibody; the development of the use thereof is limited.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Human artificial chromosome vector
  • Human artificial chromosome vector
  • Human artificial chromosome vector

Examples

Experimental program
Comparison scheme
Effect test

example

Example 1

Construction of a Targeting Vector

[0167](1) Construction of a Targeting Vector pTEL'hisDpurolox2272F9R9

[0168]Methods described in the publication (Kuroiwa et al., Nat Biotechnol. 18: 1086-1090, 2000, Kuroiwa et al., Nat Biotechnol. 20: 889-894, 2002 and Kuroiwa et al., Nat Biotechnol. 27: 173-181, 2009) were basically used for construction of a targeting vector.

[0169]Specifically, a genomic DNA fragment Dk-F9R9 used as a homology arm was amplified by PCR consisting of 40 cycles of 98° C. for 10 seconds and 68° C. for 9 minutes by using two primer DNAs of kD-F9 (5′-tcgaggatccgccagggagacagatgccaagtacggtttag-3′) (SEQ ID NO:1) and kD-R9 (5′-tcgaggatccaggatctttgggggactgaatggggtgtgct-3′) (SEQ ID NO:2) and a genomic DNA of a chicken DT40 cell line KTL1 (Kuroiwa et al., Nat. Biotechnol. 27: 173-181, 2009) having the human chromosome 2 as a template.

[0170]Subsequently, the plasmid pTEL'hisDpurolox2272 was constructed in the following order.

[0171]First, the plasmid pPURlox2272 was co...

example 2

Construction of KSL-HAC

[0210](1) Modification of the Human Chromosome 2 in a Chicken DT40 Cell

[0211]In order to generate a deletion at the AP104134 site of the human chromosome 2 and insert a lox2272 sequence and a promoterless puror cassette, the targeting vector pTEL'hisDpurolox2272F9R9 was linearized with SrfI (Stratagene) and introduced into KTL1 (Kuroiwa et al., Nat. Biotechnol. 27: 173-181, 2009) which was a chicken DT40 cell line having the human chromosome 2 fragment digested at the CD8A gene locus by electroporation (550 V, 25 μF). The electroporation of the DT40 cell was carried out by a method described in the publication (Kuroiwa et al., Nat. Biotechnol. 18: 1086-1090, 2000).

[0212]Colonies were subjected to selection by histidinol (0.5 mg / ml, Sigma) for two weeks and the sensitivity to puromycin (1 μg / ml, Sigma) was measured as an index of deletion of the puror cassette on the CD8A gene locus.

[0213]The chromosome DNA was extracted from a colony having the puromycin sensi...

example 3

Construction of KSL-HACΔ

[0259](1) Modification of the Human Chromosome 14 in a DT40 Cell

[0260]In order to integrate a lox511 sequence and a CAG promoter on the AL512355 site which is positioned on the centromere side about 300 kb from the IgH gene locus, the targeting vector pSC355CAGlox511hisDDT linearized with SrfI (Stratagene) was introduced into the DT40 cell maintaining an intact human chromosome 14 labeled with pSTneo [Katoh et al., Cell Structure and Function, 12, 575-580, 1987; Japanese Collection of Research Biologicals (JCRB) Bank, Deposit Number VE039] by electroporation (550 V, 25 μF). The electroporation method into the DT40 cell is described in the publication (Kuroiwa et al., Nat. Biotechnol. 18: 1086-1090, 2000).

[0261]The colony was subjected to selection by histidinol (0.5 mg / ml, Sigma) for two weeks, and thus a genomic DNA extracted from the resistant colony was subjected to PCR screening.

[0262]PCR was carried out with 40 cycles of 98° C. for 10 seconds and 68° C. ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
concentrationaaaaaaaaaa
humidityaaaaaaaaaa
temperatureaaaaaaaaaa
Login to View More

Abstract

A human artificial chromosome vector comprising a human antibody heavy chain gene, a human antibody light chain gene, and a human antibody surrogate light chain gene.

Description

TECHNICAL FIELD[0001]The present invention relates to a human artificial chromosome vector comprising a human antibody heavy chain gene, a human antibody light chain gene, and a human antibody surrogate light chain gene, an animal having the human artificial chromosome vector, and a method for producing a human antibody.BACKGROUND ART[0002]The development of a technology of producing a chimeric animal by fusing micronuclei comprising human chromosome fragments with cells having pluripotent differentiation to obtain hybrid cells allows to prepare a non-human animal maintaining large exogenous genes to be produced (Non-Patent Document 1 and Patent Document 1).[0003]Subsequently, a method for constructing a desired human artificial chromosome (hereinafter abbreviated to HAC) vector to produce the non-human animal has been proposed, by which the HAC including a wide range of human antibody gene loci has been established.[0004]First, as a method for modifying a chromosome fragment to be ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A01K67/027C12N15/85
CPCC07K16/00C07K16/1278C12N15/85C12N2800/208A01K2267/01A01K2207/15A01K2217/072A01K2227/101C12N15/8509A01K67/0278A01K2217/052
Inventor KUROIWA, YOSHIMIMATSUSHITA, HIROAKISANO, AKIKO
Owner SANFORD APPLIED BIOSCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com